OUR PORTFOLIO

OUR COMPANIES REDEFINE THE THERAPEUTICS OF TOMORROW

carm600_edited.png
  • LinkedIn - Grey Circle

CARMINE THERAPEUTICS

Carmine Therapeutics is an Esco Ventures X company pioneering a powerful new class of genetic medicines based on engineered red blood cells extracellular vesicles (RBCEVs), founded in 2019 by Esco Ventures and Professors Harvey Lodish, Minh Le and Jiahai Shi.

  • LinkedIn - Grey Circle

PAIRX BIO

PairX Bio Pte Ltd is developing next generation cancer immunotherapies targeting shared tumor-associated antigens derived from aberrantly spliced proteins. The foundational technology was developed at Duke-NUS Medical School in Prof. David Epstein’s lab.

  • LinkedIn - Grey Circle
  • Twitter - Grey Circle
  • Facebook - Grey Circle
  • G+ - Grey Circle

HUMMINGBIRD BIOSCIENCE

Hummingbird Bioscience focuses on the discovery and early development of oncology drugs, from pre-clinical target validation to proof-of-concept (Phase II Clinical Trials).

EVX07

To be disclosed

EVX08

To be disclosed

EVX White.png
  • LinkedIn - White Circle

SINGAPORE

LaunchPad @ one-north

71 Ayer Rajah Crescent

#03-20/21/23/24

Singapore 139951

UNITED STATES

Cambridge Innovation Center

One Broadway, Kendall Square

Cambridge MA 02142

CHINA

Biotech Innovation Works

No.29 Life Park Road

Room 202-010, Block D

Changping District, Beijing, China, 102206

© 2020 by Esco Ventures X Pte. Ltd.